
    
      This is a prospective, non-randomized study designed to assess the feasibility of the TAMBE
      Device in the treatment of patients with aortic aneurysms involving the visceral branch
      vessels. A maximum of 10 Subjects will be treated under this Protocol. This clinical study
      will include up to six sites in the US. Each enrolled subject will undergo periodic follow-up
      evaluations involving physical exams, contrast-enhanced computed tomography (CT) of chest,
      abdomen and pelvis, creatinine measurement, abdominal ultrasound (optional) at specific,
      protocol-defined intervals for a period of five years following the GORE® EXCLUDER®
      Thoracoabdominal Branch Endoprosthesis impant.
    
  